Androgen Metabolism and Reproductive Outcome
NCT02106676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2015-11-25
Summary
The aim of this study is to determine maternal androgen metabolism during pregnancy and the impact of androgen disorders on mothers and infants.
Conditions
- Polycystic Ovary Syndrome
- Healthy Pregnant Women
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- Austria
Study Locations
More Related Trials
-
Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)
NCT00606671 ·Status: COMPLETED
-
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst
NCT03456570 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
NCT03905603 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome
NCT03088046 ·Status: COMPLETED ·Phase: NA
-
Adrenal Hyperplasia Among Young People With PCOS
NCT01313455 ·Status: COMPLETED
-
Phlebotomy and Polycystic Ovary Syndrome
NCT02460445 ·Status: COMPLETED ·Phase: NA
-
Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands
NCT00364949 ·Status: COMPLETED
-
Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
NCT04327934 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
NCT03142633 ·Status: COMPLETED
-
Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin
NCT03483792 ·Status: COMPLETED
-
Phenotyping of Patients With Polycystic Ovary Syndrome
NCT07339930 ·Status: RECRUITING
-
Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome
NCT05246865 ·Status: UNKNOWN ·Phase: NA
-
Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
NCT02145247 ·Status: COMPLETED ·Phase: NA
-
The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2
NCT05647356 ·Status: UNKNOWN ·Phase: NA
-
Congenital Uterine Anomalies & Pregnancy in Polycystic Ovarian Syndrome
NCT04776915 ·Status: UNKNOWN
-
Androgen Responses to hCG and Ovarian Morphology in PCOS
NCT03489668 ·Status: UNKNOWN ·Phase: NA
-
Quality of Life in Normogonadotropic Anovulation
NCT06208995 ·Status: COMPLETED
-
Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
NCT01360996 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome
NCT00492882 ·Status: COMPLETED
-
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
NCT03652987 ·Status: SUSPENDED
-
Adipokines in Polycystic Ovary Syndrome
NCT06793072 ·Status: RECRUITING
-
the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome
NCT01752270 ·Status: UNKNOWN ·Phase: PHASE4
-
Molecular Basis of PCOS in Oocytes and Surrounding Cells
NCT04493788 ·Status: UNKNOWN
-
Presentations of Hyperandrogenic Phenotypes in Taiwanese Women
NCT01940666 ·Status: COMPLETED
-
CoPPer Study - Complications of Polycystic Ovary Syndrome (PCOS) Pregnancy: Evaluating Risk
NCT00821379 ·Status: COMPLETED